Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine

Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine

Introduction The safety and efficacy of combination therapy comprising immune checkpoint inhibitors and cancer‐specific peptide vaccines have not yet been established. Case presentation A 71‐year‐old female metastatic renal cell carcinoma patient with multiple lung and pleural metastases. She had be...

Full description

Bibliographic Details
Main Authors: Ryoma Kurahashi, Takanobu Motoshima, Yumi Fukushima, Yoji Murakami, Junji Yatsuda, Takahiro Yamaguchi, Yutaka Sugiyama, Satoshi Fukushima, Yoshihiro Komohara, Shigetaka Suekane, Tomomi Kamba
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:IJU Case Reports
Subjects:
complete response
metastatic renal cell carcinoma
nivolumab
peptide vaccine
Online Access:https://doi.org/10.1002/iju5.12139

Internet

https://doi.org/10.1002/iju5.12139

Similar Items